Carregant...
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms of particular interest: dopaminergic, cholinerg...
Guardat en:
| Publicat a: | Schizophr Res Cogn |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4824953/ https://ncbi.nlm.nih.gov/pubmed/27069875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scog.2016.02.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|